Skip to content

Estramustine phosphate

Drug profile

Also known as: emcyt, estramustine phosphate sodium

OfmFDA approved

Data last refreshed: (DrugCentral release 2024-11-01)

Key facts

Estramustine phosphate is an ofm drug catalogued in DrugCentral. It was first approved by the FDA in 1981. DrugCentral lists 5 molecular targets, including PTPN11, INPPL1 and PTPN6.

  • Approval status: ofm (first approved 1981 by the FDA).
  • Molecular targets: PTPN11, INPPL1, PTPN6 and PTPN1 (5 listed in DrugCentral).
  • Molecular formula: C23H32Cl2NO6P; molecular weight 520.38 g/mol.

Mechanism & targets

Molecular targets (5)

Regulatory approvals (1)

DateAgencyMarketed asApplicantOrphan
1981-12-24FDA—PHARMACIA AND UPJOHN

Reported adverse-event signals

Strongest FDA FAERS disproportionality signals (log-likelihood ratio). A signal is a statistical association in spontaneous reports, not proof that the drug causes the event.

MedDRA termLLR
Osteonecrosis of jaw94.6

Chemical structure

Molecular formulaC23H32Cl2NO6P
Molecular weight520.38 g/mol
CAS number4891-15-0
InChIKeyADFOJJHRTBFFOF-RBRWEJTLSA-N
PubChem CID259329
C[C@]12CC[C@H]3[C@@H](CCC4=C3C=CC(OC(=O)N(CCCl)CCCl)=C4)[C@@H]1CC[C@@H]2OP(O)(O)=O

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

How does Estramustine phosphate work?

Its molecular targets in DrugCentral include PTPN11, INPPL1, PTPN6 and PTPN1.

When was Estramustine phosphate first approved?

Estramustine phosphate was first approved by the FDA in 1981.

What is the chemical formula of Estramustine phosphate?

Estramustine phosphate has the molecular formula C23H32Cl2NO6P and a molecular weight of 520.38 g/mol.

Browse: all drugs starting with E · drug guides by category · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.

Quick facts

StatusOFM
First approval1981-12-24
AgencyFDA
Targets5
Indications0
FormulaC23H32Cl2NO6P
DrugCentral ID1066
Interactive profile